Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation

BACKGROUND: Although immunotherapy combined with targeted therapy can be effective for hepatocellular carcinoma (HCC), not all HCC patients respond to this treatment. Models for predicting tumour response in HCC patients receiving immunotherapy combined with targeted therapy are lacking. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qichen, Deng, Yiqiao, Zhao, Chuanhua, Huang, Zhen, Zhang, Wen, Yang, Yi, Bai, Yuxian, Tu, Jianfei, Li, Bo, Wu, Wei, Mao, Xianhai, Lv, Jing, Song, Tianqiang, Dai, Wenxiang, Zhao, Jianjun, Bi, Xinyu, Li, Zhiyu, Zhou, Jianguo, Zhang, Yefan, Chen, Xiao, Zhou, Aiping, Cai, Jianqiang, Xu, Jianming, Zhao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061481/
https://www.ncbi.nlm.nih.gov/pubmed/37007564
http://dx.doi.org/10.21037/atm-22-3045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061481/
https://www.ncbi.nlm.nih.gov/pubmed/37007564
http://dx.doi.org/10.21037/atm-22-3045

Ejemplares similares